The list of drugs, flagged by the Central Drugs Standard Control Organisation (CDSCO) in its monthly survey report, also contained metformin, used in the treatment of diabetes, besides paracetamol.
(File Photo)
The apex drug regulator has found samples of four drugs, including the commonly used calcium supplement Shelcal 500 and antacid Pan D, as spurious, while samples of 49 others were listed as Not of Standard Quality (NSQ).
The list of drugs, flagged by the Central Drugs Standard Control Organisation (CDSCO) in its monthly survey report, also contained metformin, used in the treatment of diabetes, besides paracetamol.
The survey was part of a routine exercise by the drug regulator during which medicines are randomly tested for quality.
Drug Controller General of India Dr Rajeev Singh Raghuvanshi said the NSQ drugs had “failed in some of the specified… quality parameters”. “And then there are four spurious drugs. These have not been manufactured by the brands that have been mentioned on the packaging,” he said. All medicines named in the NSQ list do not have any quality problem. Only the medicine manufactured by the particular company and the particular batch mentioned in the list has failed on quality parameters,” Raghuvanshi added.
Raghuvanshi said that around 3,000 samples are tested every month and “around 1.5% fail on average a month”.
